Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Valent U.S.A main competitors are Bayer, Verbatim, and Zyvex.
Competitor Summary. See how Valent U.S.A compares to its main competitors:
| Company | Founding date | Zippia score | Headquarters | # of Locations | Revenue | Employees |
|---|---|---|---|---|---|---|
| 1988 | 4.8 | San Ramon, CA | 1 | $500.0M | 341 | |
| 2010 | 4.6 | New Brighton, MN | 2 | $4.3M | 59 | |
| 1883 | 4.9 | Philadelphia, PA | 7 | $4.2B | 6,500 | |
| 2000 | 4.3 | Libertyville, IL | 1 | $35.4M | 100 | |
| 1866 | 4.8 | Philadelphia, PA | 1 | $5.3B | 12,650 | |
| 1969 | 3.5 | Charlotte, NC | 1 | $13.0M | 510 | |
| 1906 | 4.8 | Schenectady, NY | 2 | $1.8B | 2,700 | |
| 1973 | 4.7 | Pittsburgh, PA | 8 | $17.0B | 20,735 | |
| 1987 | 3.7 | Portland, OR | 1 | $920,000 | 50 | |
| 2006 | 4.1 | Norcross, GA | 2 | $29.0M | 50 | |
| 1983 | 4.0 | Knoxville, TN | 1 | $12.0M | 112 | |
| 1957 | 4.4 | Erwin, TN | 1 | $420.0M | 750 | |
| 1998 | 3.9 | Bluffdale, UT | 1 | $5.5M | 82 | |
| 1894 | 4.2 | Northbrook, IL | 25 | $2.5B | 12,000 | |
| 2000 | 4.9 | Mount Vernon, IN | 1 | $1.4B | 1,342 | |
| 1997 | 4.6 | Richardson, TX | 4 | $150.0M | 600 | |
Mammotome | 2008 | 4.0 | Cincinnati, OH | 1 | $1.4M | 2 |
Rate Valent U.S.A's competitiveness in the market.
| Company | Highest salary | Hourly salary |
|---|---|---|
Valent U.S.A | $85,200 | $40.96 |
FMC | $98,005 | $47.12 |
SI Group | $97,730 | $46.99 |
SABIC Innovative Plastics | $91,515 | $44.00 |
Axalta | $89,119 | $42.85 |
Bayer | $83,823 | $40.30 |
Valent BioSciences | $81,292 | $39.08 |
Nuclear Fuel Services | $81,180 | $39.03 |
Zyvex | $72,305 | $34.76 |
Mammotome | $68,348 | $32.86 |
UL | $67,863 | $32.63 |
Verbatim | $66,022 | $31.74 |
Biologic | $60,120 | $28.90 |
Listen Technologies | $60,062 | $28.88 |
Calyxt | $58,571 | $28.16 |
Environments | $57,711 | $27.75 |
NanoLumens | $51,360 | $24.69 |
Do you work at Valent U.S.A?
Does Valent U.S.A effectively differentiate itself from competitors?
| Job title | Male | Female |
|---|---|---|
| Mammotome | 57% | 43% |
| Bayer | 59% | 41% |
| FMC | 67% | 33% |
| Axalta | 67% | 33% |
| SABIC Innovative Plastics | 71% | 29% |
| Valent U.S.A | - | - |
| Company | White | Hispanic or Latino | Black or African American | Asian | Unknown | Diversity score |
|---|---|---|---|---|---|---|
| 57% | 13% | 12% | 14% | 4% | 9.7 | |
| 61% | 16% | 11% | 8% | 4% | 9.9 | |
| 61% | 13% | 11% | 12% | 4% | 10.0 | |
Mammotome | 65% | 8% | 8% | 14% | 5% | 7.4 |
| 59% | 11% | 10% | 13% | 7% | 9.9 | |
| 59% | 15% | 14% | 8% | 4% | 9.7 |